Excelestar Ventures
Venture capitalAndover · Seed–Series B · 2 people tracked
Investment thesis
Excelestar Ventures, established in 2009, focuses on B2B technology and medical device companies with disruptive technology, with particular attention to founders from underrepresented groups.
Team · 2 people
from the firm's websiteFrequently asked questions
- What stage does Excelestar Ventures invest at?
- Excelestar Ventures invests at the Seed, Series A, Series B stages.
- What sectors does Excelestar Ventures focus on?
- Excelestar Ventures focuses on Medical Devices, SaaS.
- Where is Excelestar Ventures located?
- Excelestar Ventures is headquartered in Andover, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.